Kexing Biopharm secures FDA IND approval for GB05, advancing pediatric RSV treatment

Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) has received Investigational New Drug (IND) approval from the United States Food and Drug Administration (FDA) for GB05, ... Read More